0001613377-19-000006.txt : 20190617 0001613377-19-000006.hdr.sgml : 20190617 20190617161131 ACCESSION NUMBER: 0001613377-19-000006 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190617 DATE AS OF CHANGE: 20190617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SPRINGATE WAYNE S CENTRAL INDEX KEY: 0001465652 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-27072 FILM NUMBER: 19901526 MAIL ADDRESS: STREET 1: 600 MAIN STREET STREET 2: SUITE 2 CITY: RIVERTON STATE: NJ ZIP: 08077 FORMER NAME: FORMER CONFORMED NAME: Springate Wayne S. DATE OF NAME CHANGE: 20090605 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: HEMISPHERX BIOPHARMA INC CENTRAL INDEX KEY: 0000946644 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 520845822 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 BUSINESS PHONE: 215-988-0080 MAIL ADDRESS: STREET 1: 2117 SW HIGHWAY 484 CITY: OCALA STATE: FL ZIP: 32801 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2019-03-25 0 0000946644 HEMISPHERX BIOPHARMA INC HEB 0001465652 SPRINGATE WAYNE S 604 MAIN STREET RIVERTON NJ 08077 0 1 0 0 Sr. VP of Operations Common Stock 2019-03-25 4 C 0 50000 A 117273 D Common Stock 2019-05-08 4 C 0 35000 A 152273 D Each share has a stated value of $1,000 and was converted into 5,000 shares of Series B Common Stock for each of the ten shares issued. Rights offering warrants using the cashless conversion feature, were converted into .70 number of shares. Wayne S. Springate 2019-06-17